| Attributs | Valeurs |
|---|
| type
| |
| Is Part Of
| |
| Subject
| |
| Title
| - Use of cyclosporin in the treatment of steroid resistant post-keratoplasty atopic sclerokeratitis
|
| has manifestation of work
| |
| related by
| |
| Abstract
| - AIMS. To demonstrate that oral cyclosporin is successful in the management of steroid refractory post-keratoplasty atopic sclerokeratitis (PKAS). METHODS. Series of three patients. RESULTS. The patients developed PKAS between 2 and 11 days after surgery. All cases failed to respond to oral prednisolone 60-80 mg daily for 10-30 days but resolved with the addition of systemic cyclosporin 5.0-7.5 mg/kg/day. There have been no relapses following withdrawal of therapy after 3-18 months. CONCLUSIONS. PKAS is an uncommon, but severe, complication of corneal graft surgery and often responds to oral prednisolone treatment. Oral cyclosporin results in rapid resolution of PKAS in steroid unresponsive cases.
|
| article type
| |
| is part of this journal
| |
| PubMed ID
| |
